Skip to main content
Fig. 4 | Cancer Nanotechnology

Fig. 4

From: Extracellular vesicle miRNAs for predicting the efficacy of late-line treatment with anlotinib in patients with lung adenocarcinoma

Fig. 4

Unsupervised clustering and differential expression of sEV miRNAs in nonsmoking SD and PD patients. A Unsupervised hierarchical clustering of sEV miRNA profiles clearly separated into nonsmoking SD and PD samples. B–H Analysis of the miR-30a-3p, miR-150-5p, miR-941, miR-122-5p, miR-10b-5p, miR-92a-3p, and miR-150-3p levels in sEVs derived from nonsmoking SD and PD patients

Back to article page

Cancer Nanotechnology

ISSN: 1868-6966

Contact us